Nexgel Inc
NASDAQ:NXGL

Watchlist Manager
Nexgel Inc Logo
Nexgel Inc
NASDAQ:NXGL
Watchlist
Price: 4.73 USD 2.38%
Market Cap: 35.6m USD
Have any thoughts about
Nexgel Inc?
Write Note

Nexgel Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nexgel Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Nexgel Inc
NASDAQ:NXGL
Total Current Assets
$5.1m
CAGR 3-Years
141%
CAGR 5-Years
70%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Total Current Assets
$955.9m
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
6%
ICU Medical Inc
NASDAQ:ICUI
Total Current Assets
$1.3B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
11%
Align Technology Inc
NASDAQ:ALGN
Total Current Assets
$2.6B
CAGR 3-Years
2%
CAGR 5-Years
12%
CAGR 10-Years
15%
Lantheus Holdings Inc
NASDAQ:LNTH
Total Current Assets
$1.3B
CAGR 3-Years
86%
CAGR 5-Years
53%
CAGR 10-Years
31%
Merit Medical Systems Inc
NASDAQ:MMSI
Total Current Assets
$1.1B
CAGR 3-Years
33%
CAGR 5-Years
20%
CAGR 10-Years
19%
No Stocks Found

Nexgel Inc
Glance View

Market Cap
35.6m USD
Industry
Health Care

NexGel, Inc. engages in the manufacture of polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania. The company went IPO on 2021-12-22. The firm is engaged in the manufactures of high-water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The firm specializes in custom gels by capitalizing on manufacturing technologies. Its products are manufactured by using proprietary and non-proprietary mixing, coating and cross-linking technologies. The company operates as a contract manufacturer of aqueous polymer hydrogels. The company delivers medication through hydrogel patches. Its Hydrogel patches are used for transdermal applications, such as hormone replacement therapy and contraception, treatment of acne, shingles, diabetes, motion sickness, treatment of angina with nitroglycerin and treatment of smoking addiction.

NXGL Intrinsic Value
7.73 USD
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Nexgel Inc's Total Current Assets?
Total Current Assets
5.1m USD

Based on the financial report for Dec 31, 2023, Nexgel Inc's Total Current Assets amounts to 5.1m USD.

What is Nexgel Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
70%

Over the last year, the Total Current Assets growth was -33%. The average annual Total Current Assets growth rates for Nexgel Inc have been 141% over the past three years , 70% over the past five years .

Back to Top